MARKET CURRENTS
real-time news and commentary for investors
- Wednesday, April 27, 2011, 3:26 AM Johnson & Johnson (JNJ) says it will buy Swiss medical-device maker Synthes for $21.3B (1/3 cash, 2/3 stock - a 22% premium), giving it a commanding lead in the global market for surgical devices used to treat bone fractures and trauma. It's unclear whether Synthes' shareholders will be satisfied with the price.
Other date
Latest Articles
